UTMB tests Pfizer vaccine on South African COVID-19 variant

Researchers are now testing the blood of patients who have been immunized with new strains of Covid-19 to test the effectiveness of it. They are so far finding a reduction in neutralizing activity by up to three-fold, but there is still quite a bit of protection for those who get the vaccine versus someone who does not.

Researchers called the reduction modest and would still say that there is a big cushion for those with the vaccine. Thankfully the vaccine will still trigger the immune response for the body to begin creating antibodies.

Share this article

One thought on “UTMB tests Pfizer vaccine on South African COVID-19 variant”

Comments are closed.